Jubilant Ingrevia Limited Stock Price Today (NSE: JUBLINGREA)

Jubilant Ingrevia Limited

624.908.35 (1.32%)
Market Closed

Fundamental Score

...

Jubilant Ingrevia Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Jubilant Ingrevia Limited share price today is 624.90, down 1.32% on NSE/BSE as of 18 September 2026. Jubilant Ingrevia Limited (JUBLINGREA) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 6.25 (Cr). The 52-week high for JUBLINGREA share price is 774.07 and the 52-week low is 537.30. At a P/E ratio of 31.98x, JUBLINGREA is currently trading above its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 9.18% and a debt-to-equity ratio of 0.25.

Jubilant Ingrevia Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
768.20
Low
624.90
Volume
2.8L
Change
-8.97%

Jubilant Ingrevia Limited share price chart: -8.97% return over the past month. 52-week high ₹774.07, 52-week low ₹537.30.

Jubilant Ingrevia Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
624.90638.50624.90633.251.15L (Cr)
630.50641.90622.80631.952.57L (Cr)
658.05658.30627.00630.501.65L (Cr)
664.00666.80651.40658.403.14L (Cr)
674.90680.60665.00666.601.02L (Cr)
672.30678.10656.50672.753.80L (Cr)
675.35680.30664.05675.301.59L (Cr)
680.70684.95669.15675.351.07L (Cr)
694.00697.35678.00680.3091.32K (Cr)
687.00701.05686.90690.551.57L (Cr)

Jubilant Ingrevia Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
679.05701.05622.80633.25-6.74%
739.90769.70663.90674.90-8.78%
610.70773.25610.70735.70+20.47%
650.00659.90600.00608.20-6.43%
716.95769.50636.00646.20-9.87%
551.05748.80551.05713.75+29.53%
570.70596.45537.30543.70-4.73%
620.50695.92579.05585.40-5.66%
700.80774.07604.56632.86-9.70%
708.40729.00584.30700.80-1.07%
691.00755.80643.80708.05+2.47%
645.00720.00628.40689.95+6.97%

Returns & Performance

Poor

Return on Equity (ROE)

9.18%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

11.14%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

13.24%

Average operating profit margin over 5 years

Dividend Yield

0.68%

Annual dividend as % of current share price

Jubilant Ingrevia Limited Valuation Check

Poor

Price to Earnings (P/E)

31.98x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.95x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

45.22%

% shares held by company founders/management

Average

FII Holding

6.49%

% shares held by foreign institutional investors

Excellent

DII Holding

24.76%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

9.30%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

40.91%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

25.27%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

45.02%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-3.28%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

38.59%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.25x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

8.53x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

432.49 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Jubilant Ingrevia Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of JUBLINGREA across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Robust Profit Growth (40.91%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (25.27%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (45.02% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (38.59% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.25)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (8.53x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹432.49 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Strong Institutional Confidence (FII+DII: 31.25%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Risk Factors

2 factors identified

Below-Average Return on Equity (9.18%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Weak Earnings Growth (-3.28% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Jubilant Ingrevia Limited vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Jubilant Ingrevia Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
58.8/100
625
₹6.25
32.0
Average
9.18%
Poor
11.14%
Average
0.3
Excellent
38.59%
Excellent
45.02%
Excellent
0.68%
65.3/100
1568
₹159580.86
60.3
Average
23.79%
Excellent
29.92%
Excellent
0.0
Excellent
16.70%
Excellent
14.89%
Good
0.73%
42.9/100
4694
₹51636.20
84.3
Average
7.65%
Poor
10.87%
Average
0.3
Excellent
36.34%
Excellent
13.52%
Good
0.07%
62.7/100
8850
₹45397.93
57.4
Average
20.11%
Excellent
21.48%
Excellent
0.3
Excellent
20.84%
Excellent
22.95%
Excellent
0.20%
32.8/100
1650
₹22511.46
28.7
Average
9.81%
Poor
11.31%
Average
0.3
Excellent
-6.63%
Poor
12.59%
Good
0.44%
36.3/100
1629
₹21621.60
91.7
Average
9.38%
Poor
12.78%
Average
0.2
Excellent
0.00%
58.2/100
6247
₹18389.70
23.1
Average
11.47%
Average
14.24%
Average
0.0
Excellent
54.89%
Excellent
10.95%
Good
0.49%
38.7/100
496
₹17974.59
33.8
Average
7.25%
Poor
8.86%
Poor
0.8
Good
-4.35%
Poor
12.96%
Good
0.20%
52.2/100
3783
₹16377.04
25.4
Average
0.00%
Poor
14.04%
Average
0.0
Excellent
7.67%
Good
9.35%
Good
0.68%
62.09999999999999/100
5125
₹15713.25
35.9
Average
16.82%
Good
21.91%
Excellent
0.0
Excellent
28.23%
Excellent
15.86%
Excellent
0.21%
33.3/100
1229
₹13986.23
79.9
Average
5.50%
Poor
9.10%
Poor
0.5
Good
19.33%
Excellent
23.88%
Excellent
0.06%

Jubilant Ingrevia Limited PE Ratio History

Historical price-to-earnings ratio for JUBLINGREA — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202515.84₹700.8044.2x
FY 202411.55₹823.0571.3x
FY 202319.33₹508.6026.3x
FY 202229.97₹528.5517.6x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Jubilant Ingrevia Limited Dividend History

Annual cash dividends paid by JUBLINGREA — dividend yield 0.68%

Financial YearDividends Paid (₹ Cr)
FY 202579.77 Cr
FY 202478.62 Cr
FY 202379.31 Cr
FY 202245.16 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Jubilant Ingrevia Limited Quarterly Performance

Latest quarterly metrics for JUBLINGREA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

25.27%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

40.91%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

45.02%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

38.59%

Compounded annual net profit growth over 5 years

Jubilant Ingrevia Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for JUBLINGREA — calculated from daily price history

35RSI 14
Neutral — RSI 35

Momentum is balanced — neither overbought nor oversold.

SMA 50
712
▼ Price below SMA 50 — Short-term bearish
SMA 200
673
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
272K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Jubilant Ingrevia Limited Financial Statements

Annual income statement, balance sheet and cash flow for Jubilant Ingrevia Limited (JUBLINGREA) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Jubilant Ingrevia Limited

Loading latest quarterly results...

About JUBLINGREA (Jubilant Ingrevia Limited)

Jubilant Ingrevia Ltd is a dynamic player in the specialty chemicals arena, crafting intricate molecules and solutions that underpin diverse industries worldwide. They are not just... manufacturers; they are architects of chemical innovation, meticulously designing and producing specialty chemicals that serve as vital building blocks for pharmaceuticals, agrochemicals, and a host of other high-growth sectors. Their expertise lies in mastering complex chemistries, developing sustainable processes, and ensuring consistent quality, making them a trusted partner for businesses seeking reliable and cutting-edge chemical solutions. With a global footprint, Jubilant Ingrevia aims to deliver high-value products and services, driven by a commitment to research, development, and responsible manufacturing practices. The company’s prowess extends beyond mere production, encompassing a comprehensive suite of services that includes custom development and manufacturing. This allows them to collaborate closely with clients, tailoring chemical solutions to meet specific needs and challenges. Within their specialty chemicals segment, they excel in the production of pyridine derivatives, fine chemicals, and microbial control agents, offering a diverse portfolio that caters to a broad spectrum of applications. Their dedication to innovation is evident in their constant pursuit of new molecules and improved processes, ensuring that they remain at the forefront of the specialty chemicals industry. Jubilant Ingrevia constantly strengthens their market position by creating unique offerings. Beyond specialty chemicals, Jubilant Ingrevia also plays a crucial role in nutrition and health, offering solutions that contribute to improved health outcomes and enhanced nutritional value. This segment focuses on developing and manufacturing ingredients for dietary supplements, animal nutrition, and other health-related applications. Additionally, the company maintains a strong presence in chemical intermediates, providing essential raw materials for various industries. By operating across these interconnected segments, Jubilant Ingrevia demonstrates its versatility and commitment to providing a wide range of chemical solutions to meet the evolving needs of its customers and contribute to a healthier and more sustainable future. They aim to become a leading life sciences company.

Company Details

Symbol:JUBLINGREA
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Hari Shanker Bhartia B.E., B.Tech
Co-Chairman & Whole-Time Director
Mr. Deepak Jain
CEO, MD & Director
Mr. Vijay Kumar Srivastava
Chief of Operations & Whole Time Director

JUBLINGREA Share Price: Frequently Asked Questions

What is the current share price of Jubilant Ingrevia Limited?

Jubilant Ingrevia Limited (JUBLINGREA) trades at ₹624.90 on NSE and BSE. Market cap ₹6.25 (Cr). Educational data only.

What is the P/E ratio of Jubilant Ingrevia Limited?

Jubilant Ingrevia Limited has a P/E of 31.98x vs industry average 31.95x.

What is the Bull Run score for Jubilant Ingrevia Limited?

Jubilant Ingrevia Limited has a Bull Run score of 58.8/100 based on 25+ financial parameters.

Does Jubilant Ingrevia Limited pay dividends?

Jubilant Ingrevia Limited has a dividend yield of 0.68%. Past dividends don't guarantee future payments.

What is the ROE of Jubilant Ingrevia Limited?

Jubilant Ingrevia Limited has ROE of 9.18%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Jubilant Ingrevia Limited?

Jubilant Ingrevia Limited has debt-to-equity of 0.25.

Is Jubilant Ingrevia Limited a good investment?

Bull Run gives Jubilant Ingrevia Limited a score of 58.8/100. This is not investment advice — consult a SEBI-registered advisor.